Nuvectis Pharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$11.04

-1.41 (-11.33%)

As of May 16, 2:05 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +148.2% upside

Low Target $23.46

Average Target $27.40

High Target $40.51

Current Price $11.04

Current
$11.04

Target
$27.40

$23.46 $27.40 avg $40.51

Scenario Analysis

Bear Case

$23.46

112.5%

Low target

Base Case

$27.40

+148.2%

Avg target

Bull Case

$40.51

+266.9%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$13.34

-17.2% from high

52-Week Low

$5.55

+98.9% from low

Target vs 52W High

$27.40

+105.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%